JP2020506239A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020506239A5 JP2020506239A5 JP2019563340A JP2019563340A JP2020506239A5 JP 2020506239 A5 JP2020506239 A5 JP 2020506239A5 JP 2019563340 A JP2019563340 A JP 2019563340A JP 2019563340 A JP2019563340 A JP 2019563340A JP 2020506239 A5 JP2020506239 A5 JP 2020506239A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- mci
- formulation
- chelate
- doses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022164581A JP2022183238A (ja) | 2017-02-08 | 2022-10-13 | 治療用骨剤の使用方法 |
| JP2024209612A JP2025036436A (ja) | 2017-02-08 | 2024-12-02 | 治療用骨剤の使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762456191P | 2017-02-08 | 2017-02-08 | |
| US62/456,191 | 2017-02-08 | ||
| PCT/US2018/017082 WO2018148209A1 (en) | 2017-02-08 | 2018-02-06 | Method of use for therapeutic bone agents |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022164581A Division JP2022183238A (ja) | 2017-02-08 | 2022-10-13 | 治療用骨剤の使用方法 |
| JP2024209612A Division JP2025036436A (ja) | 2017-02-08 | 2024-12-02 | 治療用骨剤の使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020506239A JP2020506239A (ja) | 2020-02-27 |
| JP2020506239A5 true JP2020506239A5 (https=) | 2021-01-21 |
| JP7792746B2 JP7792746B2 (ja) | 2025-12-26 |
Family
ID=63107036
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563340A Active JP7792746B2 (ja) | 2017-02-08 | 2018-02-06 | 治療用骨剤の使用方法 |
| JP2022164581A Pending JP2022183238A (ja) | 2017-02-08 | 2022-10-13 | 治療用骨剤の使用方法 |
| JP2024209612A Withdrawn JP2025036436A (ja) | 2017-02-08 | 2024-12-02 | 治療用骨剤の使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022164581A Pending JP2022183238A (ja) | 2017-02-08 | 2022-10-13 | 治療用骨剤の使用方法 |
| JP2024209612A Withdrawn JP2025036436A (ja) | 2017-02-08 | 2024-12-02 | 治療用骨剤の使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11813339B2 (https=) |
| EP (1) | EP3579886A4 (https=) |
| JP (3) | JP7792746B2 (https=) |
| CA (1) | CA3052973C (https=) |
| WO (1) | WO2018148209A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5059412A (en) * | 1984-06-04 | 1991-10-22 | The Dow Chemical Company | Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors |
| EP1475105A1 (en) | 2003-05-09 | 2004-11-10 | Schering AG | Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial radiotherapy |
| WO2011149844A1 (en) * | 2010-05-24 | 2011-12-01 | Iso Therapeutics Group Llc | Delivery of high dose therapeutic radioisotopes to bone |
| AU2014312310A1 (en) * | 2013-08-28 | 2016-04-07 | Abbvie Stemcentrx Llc | Novel SEZ6 modulators and methods of use |
| JP6787781B2 (ja) | 2013-10-07 | 2020-11-18 | アイジーエル ファーマ，インコーポレイティド | 高純度治療用骨剤 |
| US20180104366A1 (en) | 2015-05-25 | 2018-04-19 | Isotherapeutics Group, Llc | Dotmp kit formulations for radioisotopes |
-
2018
- 2018-02-06 EP EP18751017.7A patent/EP3579886A4/en active Pending
- 2018-02-06 JP JP2019563340A patent/JP7792746B2/ja active Active
- 2018-02-06 WO PCT/US2018/017082 patent/WO2018148209A1/en not_active Ceased
- 2018-02-06 US US16/484,706 patent/US11813339B2/en active Active
- 2018-02-06 CA CA3052973A patent/CA3052973C/en active Active
-
2022
- 2022-10-13 JP JP2022164581A patent/JP2022183238A/ja active Pending
-
2024
- 2024-12-02 JP JP2024209612A patent/JP2025036436A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ward | Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels | |
| JP2020033360A5 (https=) | ||
| Suit et al. | Radiation therapy of soft tissue sarcomas | |
| JP2018076328A5 (https=) | ||
| RU2010133489A (ru) | Применение ингибиторов гамма-секретазы для лечения рака | |
| UY35624A (es) | Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington | |
| JP2006514092A5 (https=) | ||
| JP2014514271A5 (https=) | ||
| EP4578461A3 (en) | Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa | |
| Traino et al. | Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism | |
| JP7068222B2 (ja) | 高純度治療用骨剤 | |
| JP2019531308A5 (https=) | ||
| JP2019123731A5 (https=) | ||
| Kamaleshwaran et al. | Radiosynovectomy of proximal interphalangeal joint synovitis in rheumatoid arthritis treated with rhenium-188 labeled tin-colloid and imaging with single-photon emission computerized tomography/computed tomography: a first case report | |
| JP2020506239A5 (https=) | ||
| JP2005513167A5 (https=) | ||
| JP2019535830A5 (https=) | ||
| CN103908458A (zh) | 甘草次酸、甘草酸在制备预防或治疗放射性软组织损伤药物中的应用 | |
| DE3344086A1 (de) | Verwendung von azaspirogermanium-verbindungen zur behandlung von arthritis | |
| Volf | Experimental background for prompt treatment with DTPA of 239Pu-contaminated wounds | |
| TW202220650A (zh) | 5-甲基-1,2,4-噁二唑-3-基化合物之低劑量療法及調配物 | |
| RU2017132445A (ru) | Дозы панобиностата для множественной миеломы | |
| MX2021007324A (es) | Terapia oral con acido 6,8-bis-benciltio-octanoico. | |
| EP4326344A1 (en) | Methods for treatment of cancers | |
| Uzlu et al. | QT and QTc prolongation and decreased heart rate after IV administration of levamisole hydrochloride in conscious rabbits |